Blogging from BIO 5 - Biotech’s Human Rights Responsibility

Blogging from BIO 4 - “It’s a Good Time to be Irish…”

Blogging from BIO 2 - Michael J. Fox on Changing the Drug Development Game: Smaller Antes, and Show Cards Sooner

How BMS is Leveraging Open Control—They’re Hiring, Too

Patent Law Reform Vote Expected This Afternoon

Biotech Funding Rose 42% in 2006: An Interview with Ernst & Young’s Sarazen